DK0521070T3 - Vandigt suspensionspræparat til indsprøjtning, fremgangsmåde til fremstilling af samme og anvendelsederaf til fremstilling af smertestillende middel - Google Patents
Vandigt suspensionspræparat til indsprøjtning, fremgangsmåde til fremstilling af samme og anvendelsederaf til fremstilling af smertestillende middelInfo
- Publication number
- DK0521070T3 DK0521070T3 DK91906827.0T DK91906827T DK0521070T3 DK 0521070 T3 DK0521070 T3 DK 0521070T3 DK 91906827 T DK91906827 T DK 91906827T DK 0521070 T3 DK0521070 T3 DK 0521070T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- less
- injection
- aqueous suspension
- diameter
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL9000634A NL9000634A (nl) | 1990-03-20 | 1990-03-20 | Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding. |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0521070T3 true DK0521070T3 (da) | 1995-05-22 |
Family
ID=19856770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91906827.0T DK0521070T3 (da) | 1990-03-20 | 1991-03-20 | Vandigt suspensionspræparat til indsprøjtning, fremgangsmåde til fremstilling af samme og anvendelsederaf til fremstilling af smertestillende middel |
Country Status (15)
Country | Link |
---|---|
US (1) | US5346903A (fi) |
EP (1) | EP0521070B1 (fi) |
JP (1) | JPH05507466A (fi) |
AT (1) | ATE121631T1 (fi) |
AU (1) | AU646857B2 (fi) |
BR (1) | BR1100601A (fi) |
CA (1) | CA2077641C (fi) |
DE (1) | DE69109279T2 (fi) |
DK (1) | DK0521070T3 (fi) |
ES (1) | ES2074269T3 (fi) |
FI (1) | FI98890C (fi) |
GR (1) | GR3015940T3 (fi) |
NL (1) | NL9000634A (fi) |
NO (1) | NO300114B1 (fi) |
WO (1) | WO1991014455A1 (fi) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206267A (en) * | 1991-05-09 | 1993-04-27 | Morton Shulman | Pain controlling composition and method of preparation |
US5635540A (en) * | 1994-12-09 | 1997-06-03 | The University Of Virginia Patent Foundation | Stabilized topical pharmaceutical preparations |
US6077545A (en) * | 1995-10-30 | 2000-06-20 | Matrix Pharmaceuticals, Inc. | Process and composition for therapeutic cisplatin (CDDP) |
EP0910369B1 (en) * | 1996-03-26 | 2010-04-21 | Eli Lilly And Company | Benzothiophenes, formulations containing same, and methods |
US6835194B2 (en) * | 1999-03-18 | 2004-12-28 | Durect Corporation | Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
US6541021B1 (en) * | 1999-03-18 | 2003-04-01 | Durect Corporation | Devices and methods for pain management |
US7074803B2 (en) * | 2001-03-02 | 2006-07-11 | Durect Corporation | Opioid formulations |
JP2004527573A (ja) * | 2001-04-24 | 2004-09-09 | パーデュー・リサーチ・ファウンデーション | 哺乳類の神経組織損傷の治療のための方法及び組成物 |
US20030181426A1 (en) * | 2002-02-11 | 2003-09-25 | Eisenach James C. | Compositions and methods for treating pain using cyclooxygenase-1 inhibitors |
US7838034B2 (en) | 2002-07-30 | 2010-11-23 | Grunenthal Gmbh | Intravenous pharmaceutical form of administration |
DE10234784A1 (de) * | 2002-07-30 | 2004-02-19 | Günenthal GmbH | Intravenös applizierbare, pharmazeutische Darreichungsform |
US20040102476A1 (en) * | 2002-11-25 | 2004-05-27 | Chan Tai Wah | High concentration formulations of opioids and opioid derivatives |
NZ554885A (en) * | 2002-12-31 | 2009-07-31 | Altus Pharmaceuticals Inc | Complexes of hgh crystals and protamine polymers |
EP2460530A3 (en) * | 2002-12-31 | 2012-08-29 | Althea Technologies, Inc. | Human growth hormone crystals and methods for preparing them |
GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
EP1976551A4 (en) * | 2005-12-23 | 2009-12-30 | Altus Pharmaceuticals Inc | COMPOSITIONS COMPRISING COMPLEX PROTEIN CRYSTALS BY POLYCATIONS AND PROCESSING METHOD THEREOF |
EP2120869A2 (en) * | 2006-12-18 | 2009-11-25 | Altus Pharmaceuticals Inc. | Human growth hormone formulations |
FI20075091A0 (fi) * | 2007-02-09 | 2007-02-09 | Kim Lemberg | Noroksimorfoni käytettäväksi lääkeaineena |
WO2008106571A2 (en) * | 2007-02-28 | 2008-09-04 | Abbott Laboratories | Sustained release parenteral formulations of buprenorphine |
US9125867B2 (en) * | 2010-02-24 | 2015-09-08 | Invincible Biotechnology | Diversion- and/or abuse-resistant compositions and methods for making the same |
US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
GB2513060B (en) * | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
DK3215223T3 (da) | 2014-11-07 | 2020-08-03 | Indivior Uk Ltd | Buprenorphindoseringsskemaer |
US10646484B2 (en) | 2017-06-16 | 2020-05-12 | Indivior Uk Limited | Methods to treat opioid use disorder |
WO2022175977A1 (en) * | 2021-02-18 | 2022-08-25 | Navin Saxena Research And Technology Private Limited | A biodegradable implant composition and process for long term delivery of buprenorphine and use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB784659A (en) * | 1954-11-26 | 1957-10-16 | Upjohn Co | Therapeutic compositions and aqueous suspensions thereof |
US3337406A (en) * | 1963-12-12 | 1967-08-22 | Mar Sal Inc | Treatment of arteriosclerotic diseases |
EP0031603A1 (en) * | 1979-12-31 | 1981-07-08 | American Cyanamid Company | Pharmaceutical composition of matter |
US4963367A (en) * | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
US4599354A (en) * | 1985-03-11 | 1986-07-08 | Morton Shulman | Composition and method for producing prolonged pain relief |
-
1990
- 1990-03-20 NL NL9000634A patent/NL9000634A/nl not_active Application Discontinuation
-
1991
- 1991-03-20 EP EP91906827A patent/EP0521070B1/en not_active Expired - Lifetime
- 1991-03-20 WO PCT/NL1991/000042 patent/WO1991014455A1/en active IP Right Grant
- 1991-03-20 AT AT91906827T patent/ATE121631T1/de not_active IP Right Cessation
- 1991-03-20 CA CA002077641A patent/CA2077641C/en not_active Expired - Fee Related
- 1991-03-20 ES ES91906827T patent/ES2074269T3/es not_active Expired - Lifetime
- 1991-03-20 DE DE69109279T patent/DE69109279T2/de not_active Expired - Fee Related
- 1991-03-20 JP JP91507032A patent/JPH05507466A/ja active Pending
- 1991-03-20 AU AU75580/91A patent/AU646857B2/en not_active Ceased
- 1991-03-20 DK DK91906827.0T patent/DK0521070T3/da active
-
1992
- 1992-09-03 NO NO923429A patent/NO300114B1/no unknown
- 1992-09-08 FI FI924019A patent/FI98890C/fi not_active IP Right Cessation
- 1992-11-20 US US07/979,128 patent/US5346903A/en not_active Expired - Lifetime
-
1995
- 1995-04-27 GR GR950400877T patent/GR3015940T3/el unknown
-
1997
- 1997-05-13 BR BR1100601-3A patent/BR1100601A/pt active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE69109279D1 (de) | 1995-06-01 |
WO1991014455A1 (en) | 1991-10-03 |
DE69109279T2 (de) | 1995-11-09 |
ATE121631T1 (de) | 1995-05-15 |
ES2074269T3 (es) | 1995-09-01 |
FI924019A (fi) | 1992-09-08 |
CA2077641C (en) | 2001-07-03 |
FI924019A0 (fi) | 1992-09-08 |
NL9000634A (nl) | 1991-10-16 |
AU646857B2 (en) | 1994-03-10 |
EP0521070A1 (en) | 1993-01-07 |
JPH05507466A (ja) | 1993-10-28 |
FI98890C (fi) | 1997-09-10 |
NO300114B1 (no) | 1997-04-14 |
BR1100601A (pt) | 2000-04-18 |
EP0521070B1 (en) | 1995-04-26 |
CA2077641A1 (en) | 1991-09-21 |
US5346903A (en) | 1994-09-13 |
FI98890B (fi) | 1997-05-30 |
GR3015940T3 (en) | 1995-07-31 |
AU7558091A (en) | 1991-10-21 |
NO923429L (no) | 1992-09-17 |
NO923429D0 (no) | 1992-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0521070T3 (da) | Vandigt suspensionspræparat til indsprøjtning, fremgangsmåde til fremstilling af samme og anvendelsederaf til fremstilling af smertestillende middel | |
ATE149828T1 (de) | Arzneistofformulierung zur parenteralen anwendung | |
IL115878A0 (en) | Small particle formation | |
DK0787112T3 (da) | Aerogelholdig sammensætning, fremgangsmåde til dens fremstilling samt dens anvendelse | |
ATE206067T1 (de) | Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe | |
DE69309052D1 (de) | Oral anzuwendende suspension bestehend aus stabilisiertem rockenpulver eines hydratisierten cephalosporins | |
KR950701223A (ko) | 항허혈성(Anti-ichemic)약물 | |
FI970149A0 (fi) | Tiatsoli- ja tiadiatsoliyhdisteiden käyttö D3-reseptoriligandeina | |
DE59509430D1 (de) | Wärmeträgerkonzentrat, verfahren zu dessen herstellung sowie dessen verwendung und latentwärmespeicher | |
BE902760A (fr) | Benzamides substitues pharmacologiquement actifs. | |
MY118301A (en) | Local anesthetic for external use | |
ATE150735T1 (de) | Lagerstabil verkapseltes natriumpercarbonat und verfahren zu seiner herstellung | |
Fingeret | The illiterate underclass: Demythologizing an American stigma | |
KR900007319A (ko) | 살충 조성물 | |
KR910019592A (ko) | 화장용 제제 | |
Guilloteau et al. | MIBG and catecholamine storage in the brain: an in-vitro study | |
TAKAI et al. | The effect of new local anesthetics “Ultracain®” | |
Yau | Application of Vlasov's method to static, dynamic and stability problems in plate structures. | |
KR940703656A (ko) | 에이즈 바이러스 감염 저해용 조성물 | |
AU5975290A (en) | Liquid suspensions of nitrofurantoin | |
JPS57154130A (en) | Pharmaceutical composition having uterotonic activity |